Nonclassical retinoids and lung carcinogenesis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Lung Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3816/CLC.2005.N.003PMID 15694016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.

  2005cited by this paper
• Specific Chemopreventive Agents Trigger Proteasomal Degradation of G1 Cyclins: Implications for Combination Therapy

  2004cited by this paper
• A retinoid X receptor (RXR)-selective agonist bexarotene produces synergistic growth inhibitory activity with gefitinib in non-small-cell lung cancer (NSCLC) cell lines.

  2004cited by this paper
• Improved event free survival (EFS) with the novel retinoid, bexarotene (BEX) and gemcitabine/carboplatin (G/C) in non-small cell lung cancer (NSCLC)

  2004cited by this paper
• Lung cancer prevention: the guidelines.

  2003cited by this paper
• Role of the Retinoblastoma Protein in Differentiation and Senescence

  2003cited by this paper
• Retinoid Targets in Cancer Therapy and Chemoprevention

  2003cited by this paper
• Cyclin D1 as a target for chemoprevention.

  2003cited by this paper
• Retinoid receptors and their coregulators.

  2003cited by this paper
• Retinoids in cancer therapy and chemoprevention: promise meets resistance

  2003cited by this paper
• A phase 1 study of tazarotene in adults with advanced cancer

  2003cited by this paper
• Classical and novel retinoids: their targets in cancer therapy

  2002cited by this paper
• The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer.

  2002cited by this paper
• Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.

  2002cited by this paper
• Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancer.

  2002cited by this paper
• Evidence for the epidermal growth factor receptor as a target for lung cancer prevention.

  2002cited by this paper
• Optimizing bexarotene therapy for cutaneous T-cell lymphoma.

  2002cited by this paper
• Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.

  2001cited by this paper
• Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.

  2001cited by this paper
• Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.

  2001cited by this paper
• Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.

  2001cited by this paper
• Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results.

  2001cited by this paper
• Histone deacetylase inhibitors as new cancer drugs

  2001cited by this paper
• Mechanisms underlying ubiquitination.

  2001cited by this paper
• Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancer.

  2001cited by this paper
• Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

  2001cited by this paper
• The retinoids and cancer prevention mechanisms.

  2000cited by this paper
• Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.

  2000cited by this paper
• Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.

  2000cited by this paper
• Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

  2000cited by this paper
• A unified nomenclature system for the nuclear receptor superfamily

  1999cited by this paper
• Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

  1999cited by this paper
• Nuclear Retinoid Receptors and Mechanisms of Action

  1999cited by this paper
• Central hypothyroidism associated with retinoid X receptor-selective ligands.

  1999cited by this paper
• Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

  1999cited by this paper
• A Phase I study of LGD1069 in adults with advanced cancer.

  1999cited by this paper
• Expression of retinoid receptor genes and proteins in non-small-cell lung cancer.

  1999cited by this paper
• Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.

  1999cited by this paper
• Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells.

  1999cited by this paper
• Retinoic Acid Promotes Ubiquitination and Proteolysis of Cyclin D1 during Induced Tumor Cell Differentiation*

  1999cited by this paper
• 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARγ independent pathway

  1999cited by this paper
• Aberrant expression of retinoid receptors and lung carcinogenesis.

  1999cited by this paper
• A unified nomenclature system for the nuclear receptor superfamily.

  1999cited by this paper
• Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular Carcinoma

  1998cited by this paper
• Molecular Determinants of AHPN (CD437)-Induced Growth Arrest and Apoptosis in Human Lung Cancer Cell Lines

  1998cited by this paper
• Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.

  1997cited by this paper
• Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

  1997cited by this paper
• Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism.

  1997cited by this paper
• Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells

  1997cited by this paper
• Induction of apoptosis in human non‐small cell lung carcinoma cells by the novel synthetic retinoid CD437

  1997cited by this paper
• Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.

  1997cited by this paper
• Role of antioxidants and intracellular free radicals in retinamide-induced cell death.

  1997cited by this paper
• Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.

  1997cited by this paper
• Novel retinoid-related molecules as apoptosis inducers and effectve inhibitors of human lung cancer cells in vivo

  1997cited by this paper
• 4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors*

  1996cited by this paper
• Retinoic acid normalizes the increased gene transcription rate of TGF–α and EGFR in head and neck cancer cell lines

  1996cited by this paper
• Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation.

  1996cited by this paper
• A decade of molecular biology of retinoic acid receptors

  1996cited by this paper
• Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma.

  1996cited by this paper
• Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.

  1996cited by this paper
• Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.

  1996cited by this paper
• Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.

  1996cited by this paper
• Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

  1996cited by this paper
• The RXR heterodimers and orphan receptors.

  1995cited by this paper
• Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism

  1995cited by this paper
• Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.

  1995cited by this paper
• Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.

  1995cited by this paper
• Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

  1995cited by this paper
• Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid.

  1994cited by this paper
• Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.

  1994cited by this paper
• A new class of retinoids with selective inhibition of AP-1 inhibits proliferation

  1994cited by this paper
• The retinoid receptors.

  1994cited by this paper
• The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.

  1994cited by this paper
• Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.

  1993cited by this paper
• N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.

  1993cited by this paper
• Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment.

  1993cited by this paper
• Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

  1993cited by this paper
• Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells.

  1993cited by this paper
• Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

  1992cited by this paper
• Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid

  1992cited by this paper
• Retinoids selective for retinoid X receptor response pathways.

  1992cited by this paper
• Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

  1992cited by this paper
• 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

  1992cited by this paper
• 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

  1992cited by this paper
• Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.

  1992cited by this paper
• RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements.

  1991cited by this paper
• Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

  1991cited by this paper
• Identification of retinoids with nuclear receptor subtype-selective activities.

  1991cited by this paper
• RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements

  1991cited by this paper
• Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

  1990cited by this paper
• Phase I study of 13-cis-retinoic acid toxicity.

  1982cited by this paper
• TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN

  1925cited by this paper

• Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.

  2016cites this paper
• Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

  2016cites this paper
• Lung cancer chemoprevention: difficulties, promise and potential agents?

  2013cites this paper
• Cancer-Preventive Rexinoid Modulates Neutral Lipid Contents of Mammary Epithelial Cells through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism

  2012cites this paper
• Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis

  2012cites this paper
• Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.

  2011cites this paper
• Cancer Preventive Rexinoid Modulates Neutral Lipid Content of Mammary Epithelial Cells through a PPAR γ-dependent Mechanism

  2011cites this paper
• Analyse cinétique des rétinaldéhydes déshydrogénases recombinantes de type 3 et 4 de souris

  2010cites this paper
• Preventive Effects of Bexarotene and Budesonide in a Genetically Engineered Mouse Model of Small Cell Lung Cancer

  2009cites this paper
• Chemopreventive efficacy of mangiferin against benzo(a)pyrene induced lung carcinogenesis in experimental animals.

  2008cites this paper
• Response to Conventional Therapy and Targeted Molecular Therapy

  2008cites this paper
• Identification of the Retinoic Acid – Inducible Gprc 5 a As a New Lung Tumor Suppressor Gene

  2007cites this paper
• Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.

  2007cites this paper
• Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer

  2007cites this paper
• Chemotherapeutic/chemopreventive role of retinoids in chemically induced skin carcinogenesis in albino mice

  2007cites this paper
• A Proof-of-Principle Clinical Trial of Bexarotene in Patients with Non–Small Cell Lung Cancer

  2007cites this paper
• In vivo effect of piperine on serum and tissue glycoprotein levels in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice.

  2006cites this paper
• Identification of a Highly Effective Rapamycin Schedule that Markedly Reduces the Size, Multiplicity, and Phenotypic Progression of Tobacco Carcinogen–Induced Murine Lung Tumors

  2006cites this paper
• All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation.

  2006cites this paper
• Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells.

  2006cites this paper
• Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide

  2006cites this paper